A Comparison of the Short-term Effects of a Botulinum Toxin Type a and Triamcinolone Acetate Injection on Adhesive Capsulitis of the Shoulder

Overview

Journal Ann Rehabil Med

Specialty Rehabilitation Medicine

Date 2013 May 25

PMID 23705115

Citations 9

Authors

Young-Jin Joo

Se-Jin Yoon

Chang-Won Kim

Jung-Hwan Lee

Young-Jin Kim

Jung-Hoi Koo

Sun-Hong Song

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the short-term clinical effects of the intra-articular injection of botulinum toxin type A (BoNT-A) for the treatment of adhesive capsulitis.

Methods: A prospective, controlled trial compared the effects of intra-articular BoNT-A (Dysport; 200 IU, n=15) with the steroid triamcinolone acetate (TA; 20 mg, n=13) in patients suffering from adhesive capsulitis of the shoulder. All patients were evaluated using a Numeric Rating Scale (NRS) of the pain intensity and a measurement of the range of motion (ROM) at baseline (before treatment) and at 2, 4, and 8 weeks post-treatment.

Results: The NRS at 2 weeks (BoNT-A vs. TA; 5.0 vs. 5.2), 4 weeks (4.1 vs. 4.9) and 8 weeks (3.8 vs. 4.6) of both treatment groups were significantly lower than that measured at baseline (7.4 vs. 7.6). The ROM of patients' shoulders increased significantly from baseline in both treatment groups. There was no significant difference in the NRS of pain intensity or the ROM between the two groups. Reduction in the pain intensity score was maintained for 8 weeks post-injection in both groups. There were no significant adverse events in either treatment group.

Conclusion: The results suggest that there are no significant short-term differences between the intra-articular injections of BoNT-A and TA. Although BoNT-A has a high cost, it may be used as a safe alternative of TA to avoid the steroid-induced side effects or as a second-line agent, for patients who have failed to respond to the current treatments.

Citing Articles

Effect of ultrasound-guided injection of botulinum toxin type A into shoulder joint cavity on shoulder pain in poststroke patients: study protocol for a randomized controlled trial.

Zheng P, Shi Y, Qu H, Han M, Wang Z, Zeng Q Trials. 2024; 25(1):418.

PMID: 38937804 PMC: 11212400. DOI: 10.1186/s13063-024-08258-8.

Association of Range of Motion Deficit and Recurrence of Pain After Treatment of Adhesive Capsulitis.

Lee J, Lee J, Chang M Pain Ther. 2024; 13(2):241-249.

PMID: 38315379 PMC: 10928039. DOI: 10.1007/s40122-024-00578-6.

Cytokines' Role in the Pathogenesis and Their Targeting for the Prevention of Frozen Shoulder: A Narrative Review.

Alghamdi A, Alyami A, Althaqafi 2nd R, Alzeyadi A, Alrubaei F, Alyami A Cureus. 2023; 15(3):e36070.

PMID: 37056530 PMC: 10092900. DOI: 10.7759/cureus.36070.

Frozen shoulder.

Millar N, Meakins A, Struyf F, Willmore E, Campbell A, Kirwan P Nat Rev Dis Primers. 2022; 8(1):59.

PMID: 36075904 DOI: 10.1038/s41572-022-00386-2.

The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence.

Blanshan N, Krug H Toxins (Basel). 2020; 12(5).

PMID: 32397671 PMC: 7291335. DOI: 10.3390/toxins12050314.

References

Kong K, Neo J, Chua K . A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin Rehabil. 2007; 21(1):28-35. DOI: 10.1177/0269215506072082. View

Namazi H, Torabi S . Novel use of botulinum toxin to ameliorate arthrofibrosis: an experimental study in rabbits. Toxicol Pathol. 2007; 35(5):715-8. DOI: 10.1080/01926230701481923. View

Hand G, Athanasou N, Matthews T, Carr A . The pathology of frozen shoulder. J Bone Joint Surg Br. 2007; 89(7):928-32. DOI: 10.1302/0301-620X.89B7.19097. View

Tillander B, Franzen L, Karlsson M, Norlin R . Effect of steroid injections on the rotator cuff: an experimental study in rats. J Shoulder Elbow Surg. 1999; 8(3):271-4. DOI: 10.1016/s1058-2746(99)90141-6. View

Zhibo X, Miaobo Z . Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar. J Plast Reconstr Aesthet Surg. 2008; 61(9):1128-9. DOI: 10.1016/j.bjps.2008.05.003. View

Hanesch U, Heppelmann B, Schmidt R . Substance P- and calcitonin gene-related peptide immunoreactivity in primary afferent neurons of the cat's knee joint. Neuroscience. 1991; 45(1):185-93. DOI: 10.1016/0306-4522(91)90114-4. View

Brue S, Valentin A, Forssblad M, Werner S, Mikkelsen C, Cerulli G . Idiopathic adhesive capsulitis of the shoulder: a review. Knee Surg Sports Traumatol Arthrosc. 2007; 15(8):1048-54. DOI: 10.1007/s00167-007-0291-2. View

Kido M, Kiyoshima T, Kondo T, Ayasaka N, Moroi R, Terada Y . Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat temporomandibular joint. J Dent Res. 1993; 72(3):592-8. DOI: 10.1177/00220345930720030701. View

Bunker T, ANTHONY P . The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br. 1995; 77(5):677-83. View

10.

Schaible H, Ebersberger A, Segond von Banchet G . Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002; 966:343-54. DOI: 10.1111/j.1749-6632.2002.tb04234.x. View

11.

Grey R . The natural history of "idiopathic" frozen shoulder. J Bone Joint Surg Am. 1978; 60(4):564. View

12.

DePalma A . The classic. Loss of scapulohumeral motion (frozen shoulder). Ann Surg. 1952;135:193-204. Clin Orthop Relat Res. 2008; 466(3):552-60. PMC: 2505213. DOI: 10.1007/s11999-007-0101-7. View

13.

Mense S . Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol. 2004; 251 Suppl 1:I1-7. DOI: 10.1007/s00415-004-1102-z. View

14.

Singh J, Mahowald M . Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases. Joint Bone Spine. 2008; 76(2):190-4. DOI: 10.1016/j.jbspin.2008.05.006. View

15.

Milgrom C, Novack V, Weil Y, Jaber S, Radeva-Petrova D, Finestone A . Risk factors for idiopathic frozen shoulder. Isr Med Assoc J. 2008; 10(5):361-4. View

16.

Shah N, Lewis M . Shoulder adhesive capsulitis: systematic review of randomised trials using multiple corticosteroid injections. Br J Gen Pract. 2007; 57(541):662-7. PMC: 2099674. View

17.

Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E . Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol. 1995; 40(2):127-35. DOI: 10.1016/0003-9969(94)00141-w. View

18.

Goyal N . Intra-articular knee joint Botox injection for chronic osteoarthritic pain. Anaesth Intensive Care. 2008; 36(1):123. View

19.

Cui M, Khanijou S, Rubino J, Aoki K . Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004; 107(1-2):125-33. DOI: 10.1016/j.pain.2003.10.008. View

20.

Knutson G . The role of the gamma-motor system in increasing muscle tone and muscle pain syndromes: a review of the Johansson/Sojka hypothesis. J Manipulative Physiol Ther. 2000; 23(8):564-72. DOI: 10.1067/mmt.2000.109674. View